Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID-19.
Field BCT, Ruan Y, Várnai KA, Davies J, Ryder REJ, Gandhi R, Harris S, Nagi D, Patel D, Kempegowda P, Wild SH, Wilmot EG, Khunti K, Rea R, Narendran P; ABCD COVID-19 Audit Group. Field BCT, et al. Among authors: narendran p. Diabetes Obes Metab. 2023 Jul;25(7):2012-2022. doi: 10.1111/dom.15076. Epub 2023 Apr 25. Diabetes Obes Metab. 2023. PMID: 37016487
Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19.
Khunti K, Ruan Y, Davies J, Field BCT, Harris S, Kosiborod M, Nagi D, Narendran P, Patel D, Ryder REJ, Várnai KA, Wild SH, Wilmot EG, Rea R; ABCD COVID-19 Diabetes National Audit Investigators. Khunti K, et al. Among authors: narendran p. Diabetes Care. 2022 Sep 8:dc220357. doi: 10.2337/dc22-0357. Online ahead of print. Diabetes Care. 2022. PMID: 36074663
Impact of the CamAPS FX hybrid closed-loop insulin delivery system on sleep traits in older adults with type 1 diabetes.
Thabit H, Boughton C, Mubita W, Rubio J, Mader JK, Narendran P, Evans M, Leelarathna L, Wilinska ME, Fullwood C, Gregory AM, Hovorka R, Rutter MK. Thabit H, et al. Among authors: narendran p. Diabetes Obes Metab. 2023 Mar;25(3):889-893. doi: 10.1111/dom.14914. Epub 2022 Nov 15. Diabetes Obes Metab. 2023. PMID: 36335565 Free PMC article. No abstract available.
Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study.
Crabtree TSJ, Griffin TP, Yap YW, Narendran P, Gallen G, Furlong N, Cranston I, Chakera A, Philbey C, Karamat MA, Saraf S, Kamaruddin S, Gurnell E, Chapman A, Hussain S, Elliott J, Leelarathna L, Ryder REJ, Hammond P, Lumb A, Choudhary P, Wilmot EG; ABCD Closed-Loop Audit Contributors. Crabtree TSJ, et al. Among authors: narendran p. Diabetes Care. 2023 Oct 1;46(10):1831-1838. doi: 10.2337/dc23-0635. Diabetes Care. 2023. PMID: 37566697 Free PMC article.
Estimating the cost-effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England.
Elliott RA, Rogers G, Evans ML, Neupane S, Rayman G, Lumley S, Cranston I, Narendran P, Sutton CJ, Taxiarchi VP, Burns M, Thabit H, Wilmot EG, Leelarathna L; FLASH-UK Trial Study Group. Elliott RA, et al. Among authors: narendran p. Diabet Med. 2024 Mar;41(3):e15232. doi: 10.1111/dme.15232. Epub 2023 Oct 6. Diabet Med. 2024. PMID: 37750427
Impact of hybrid closed-loop insulin delivery on cardiac rhythm in older adults with type 1 diabetes: A post hoc analysis of trial data.
Thabit H, Boughton C, Mubita W, Rubio J, Allen S, Heugh R, Mader JK, Narendran P, Evans M, Leelarathna L, Wilinska ME, Fullwood C, Garratt C, Hovorka R, Rutter MK. Thabit H, et al. Among authors: narendran p. Diabetes Obes Metab. 2024 Mar;26(3):1105-1109. doi: 10.1111/dom.15366. Epub 2023 Nov 20. Diabetes Obes Metab. 2024. PMID: 37984425 No abstract available.
Safety of User-Initiated Intensification of Insulin Delivery Using Cambridge Hybrid Closed-Loop Algorithm.
Ware J, Wilinska ME, Ruan Y, Allen JM, Boughton CK, Hartnell S, Bally L, de Beaufort C, Besser REJ, Campbell FM, Draxlbauer K, Elleri D, Evans ML, Fröhlich-Reiterer E, Ghatak A, Hofer SE, Kapellen TM, Leelarathna L, Mader JK, Mubita WM, Narendran P, Poettler T, Rami-Merhar B, Tauschmann M, Randell T, Thabit H, Thankamony A, Trevelyan N, Hovorka R. Ware J, et al. Among authors: narendran p. J Diabetes Sci Technol. 2022 Dec 8:19322968221141924. doi: 10.1177/19322968221141924. Online ahead of print. J Diabetes Sci Technol. 2022. PMID: 36475908 Free article.
What does the licensing of teplizumab mean for diabetes care?
Quinn LM, Swaby R, Tatovic D, Narendran P, Besser REJ, Dayan CM. Quinn LM, et al. Among authors: narendran p. Diabetes Obes Metab. 2023 Aug;25(8):2051-2057. doi: 10.1111/dom.15071. Epub 2023 Apr 24. Diabetes Obes Metab. 2023. PMID: 36999237 No abstract available.
147 results